Absolutely.

The science looks strong. There is a whole pipeline of possible indications. Patent protection continues to be assigned. 

Often, Big Pharma will be willing to buy a company just for one big drug. 

With RVX+/-Zenith, they'd be acquiring an entire platform. 

FDA approval of BETONMACE would signal to the market that Phase 3 results could lead to FDA approval. Analysts could then truly plug numbers in to their calculators. 

Bfw